Leo Siu
About Leo Siu
Leo Siu is a scientist with extensive experience in cancer and immunology research, currently working at Avro Life Science in Kitchener, Ontario. He has authored numerous publications and has expertise in the design and testing of functional polymers and nanoparticles.
Current Role at Avro Life Science
Currently, Leo Siu works as a Scientist at Avro Life Science in Kitchener, Ontario, Canada. He has held this position since 2021, contributing to the company's research and development efforts. His role involves applying his expertise in functional polymers and lipid nanoparticles to advance scientific knowledge and product development.
Previous Experience at Bio Basic Inc.
From 2015 to 2017, Leo Siu served as Team Lead for Gene Synthesis at Bio Basic Inc. in Markham, Ontario. During his two years in this role, he managed projects related to gene synthesis, leveraging his skills in molecular biology and biotechnology.
Educational Background in Chemistry
Leo Siu studied Chemistry at The Hong Kong University of Science and Technology, where he earned a Bachelor of Science (B.Sc.) from 2001 to 2004. He furthered his education at The University of Hong Kong, obtaining a Master of Philosophy (M.Phil.) in Chemistry from 2007 to 2009. He also completed a Doctor of Philosophy (PhD) in Pathology at Western University from 2010 to 2014.
Research Contributions and Publications
Leo Siu has authored a book chapter and has published a total of eight research articles, including two as the first author. He has presented his research findings at 11 scientific conferences, demonstrating his ability to communicate complex scientific concepts effectively.
Expertise in Cancer and Immunology Research
Leo Siu possesses extensive expertise in the design, synthesis, characterization, formulation, and testing of functional polymers, nanoparticles, and lipid nanoparticles (LNPs). His research background includes a strong focus on cancer and immunology, with notable work on the use of carbon nanotubes for topical siRNA delivery, which achieved a significant inhibition of melanoma progression in a rodent model.